Relationships Between the Use of Antimalarial Drugs in Pregnancy and Plasmodium Falciparum Resistance [clinicaltrials:NCT00140517]
Relationships Between the Use of Antimalarial Drugs in Pregnancy and Plasmodium Falciparum Resistance [clinicaltrials:NCT00140517]
Bio2RDF identifier
NCT00140517
Bio2RDF namespace
clinicaltrials
Bio2RDF uri
http://bio2rdf.org/clinicaltrials:NCT00140517
identifiers.org URI
authority [clinicaltrials_vocabulary:authority]
brief summary [clinicaltrials_vocabulary:brief-summary]
Plasmodium falciparum r ...... ce to CQ and SP
is low.
brief title [clinicaltrials_vocabulary:brief-title]
Relationships Between the Use ...... asmodium Falciparum Resistance
clinicaltrials_vocabulary:primary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:primary-outcome]
clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]
collaborator [clinicaltrials_vocabulary:collaborator]
completion date [clinicaltrials_vocabulary:completion-date]
2008-03-01T00:00:00Z
condition [clinicaltrials_vocabulary:condition]
condition browse [clinicaltrials_vocabulary:condition-browse]
condition mesh [clinicaltrials_vocabulary:condition-mesh]
country [clinicaltrials_vocabulary:country]
detailed description [clinicaltrials_vocabulary:detailed-description]
OBJECTIVES Overall obje ...... will be used when necessary.
download date [clinicaltrials_vocabulary:download-date]
ClinicalTrials.gov processed this data on August 10, 2015
eligibility [clinicaltrials_vocabulary:eligibility]
enrollment [clinicaltrials_vocabulary:enrollment]
firstreceived date [clinicaltrials_vocabulary:firstreceived-date]
2005-08-31T00:00:00Z
has expanded access [clinicaltrials_vocabulary:has-expanded-access]
intervention [clinicaltrials_vocabulary:intervention]
intervention browse [clinicaltrials_vocabulary:intervention-browse]
is fda regulated [clinicaltrials_vocabulary:is-fda-regulated]
keyword [clinicaltrials_vocabulary:keyword]
Plasmodium falciparum
resistance
lastchanged date [clinicaltrials_vocabulary:lastchanged-date]
2009-03-30T00:00:00Z
lead sponsor [clinicaltrials_vocabulary:lead-sponsor]
link [clinicaltrials_vocabulary:link]
location [clinicaltrials_vocabulary:location]
nct id [clinicaltrials_vocabulary:nct-id]
NCT00140517
official title [clinicaltrials_vocabulary:official-title]
Relationships Between the Use ...... asmodium Falciparum Resistance
org study id [clinicaltrials_vocabulary:org-study-id]
HSR/DD/677-01/DG-CM/624-02
overall official [clinicaltrials_vocabulary:overall-official]
overall status [clinicaltrials_vocabulary:overall-status]
oversight [clinicaltrials_vocabulary:oversight]
primary completion date [clinicaltrials_vocabulary:primary-completion-date]
2007-06-01T00:00:00Z
source [clinicaltrials_vocabulary:source]
start date [clinicaltrials_vocabulary:start-date]
2002-10-01T00:00:00Z
study design [clinicaltrials_vocabulary:study-design]
study type [clinicaltrials_vocabulary:study-type]
url [clinicaltrials_vocabulary:url]
verification date [clinicaltrials_vocabulary:verification-date]
2009-03-01T00:00:00Z
identifier
clinicaltrials:NCT00140517
title
Relationships Between the Use ...... asmodium Falciparum Resistance
@en
type
label
Relationships Between the Use ...... e [clinicaltrials:NCT00140517]
@en